Trial · NCT00450437
Adverse events82
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 82
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Injection site pain | General disorders | Novartis MenACWY Vaccine | 1,106 | 2,649 | |
| other | Injection site pain | General disorders | Licensed Meningococcal Vaccine | 424 | 875 | |
| other | Injection site erythema | General disorders | Novartis MenACWY Vaccine | 414 | 2,649 | |
| other | Injection site erythema | General disorders | Licensed Meningococcal Vaccine | 126 | 875 | |
| other | Injection site induration | General disorders | Novartis MenACWY Vaccine | 324 | 2,649 | |
| other | Injection site induration | General disorders | Licensed Meningococcal Vaccine | 88 | 875 | |
| other | Chills | General disorders | Novartis MenACWY Vaccine | 169 | 2,649 | |
| other | Chills | General disorders | Licensed Meningococcal Vaccine | 50 | 875 | |
| other | Nausea | Gastrointestinal disorders | Novartis MenACWY Vaccine | 265 | 2,649 | |
| other | Nausea | Gastrointestinal disorders | Licensed Meningococcal Vaccine | 66 | 875 | |
| other | Malaise | General disorders | Novartis MenACWY Vaccine | 280 | 2,649 | |
| other | Malaise | General disorders | Licensed Meningococcal Vaccine | 100 | 875 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Novartis MenACWY Vaccine | 453 | 2,649 | |
| other | Myalgia | Musculoskeletal and connective tissue disorders | Licensed Meningococcal Vaccine | 150 | 875 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Novartis MenACWY Vaccine | 211 | 2,649 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Licensed Meningococcal Vaccine | 59 | 875 | |
| other | Headache | Nervous system disorders | Novartis MenACWY Vaccine | 740 | 2,649 | |
| other | Headache | Nervous system disorders | Licensed Meningococcal Vaccine | 240 | 875 | |
| serious | Vitello-Intestinal Duct Remnant | Congenital, familial and genetic disorders | Novartis MenACWY Vaccine | 1 | 2,649 | 1 |
| serious | Vitello-Intestinal Duct Remnant | Congenital, familial and genetic disorders | Licensed Meningococcal Vaccine | 0 | 875 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00450437/events